Publication related to RSI or an RSI staff member

Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population.

OBJECTIVE: To examine prescription Food and Drug Administration (FDA) C, D and X drugs in general obstetric population. STUDY DESIGN: Historical cohort study. RESULT: A total of 18 575 women who gave a birth in Saskatchewan between January 1997 and December 2000 were included. Among them, 3604 (19.4%) received FDA C, D or X drugs at least once during pregnancy. The pregnancy exposure rates were 15.8, 5.2 and 3.9%, respectively, for category C, D and X drugs, and were 11.2, 7.3 and 8.2%, respectively, in the first, second and third trimesters. Salbutamol (albuterol), trimethoprim/sulfamethoxazole (co-trimoxazole), ibuprofen, naproxen and oral contraceptives were the most common C, D, X drugs used during pregnancy. CONCLUSION: About one in every five women uses FDA C, D and X drugs at least once during pregnancy, and the most common prescription drugs in pregnancy are antiasthmatic, antibiotics, nonsteroid anti-inflammation drugs, antianxiety or antidepressants and oral contraceptives.

Authors

  • Wen, S W, Wen SW, OMNI Research Group, Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, Canada. swwen@ohri.ca

  • Yang, T, Yang T,

  • Krewski, D, Krewski D,

  • Yang, Q, Yang Q,

  • Nimrod, C, Nimrod C,

  • Garner, P, Garner P,

  • Fraser, W, Fraser W,

  • Olatunbosun, O, Olatunbosun O,

  • Walker, M C, Walker MC,

YEAR OF PUBLICATION: 2008
SOURCE: J Perinatol. 2008 May;28(5):324-9. doi: 10.1038/jp.2008.6. Epub 2008 Feb 21.
JOURNAL TITLE ABBREVIATION: J Perinatol
JOURNAL TITLE: Journal of perinatology : official journal of the California Perinatal Association
ISSN: 0743-8346 (Print) 0743-8346 (Linking)
VOLUME: 28
ISSUE: 5
PAGES: 324-9
PLACE OF PUBLICATION: United States
ABSTRACT:
OBJECTIVE: To examine prescription Food and Drug Administration (FDA) C, D and X drugs in general obstetric population. STUDY DESIGN: Historical cohort study. RESULT: A total of 18 575 women who gave a birth in Saskatchewan between January 1997 and December 2000 were included. Among them, 3604 (19.4%) received FDA C, D or X drugs at least once during pregnancy. The pregnancy exposure rates were 15.8, 5.2 and 3.9%, respectively, for category C, D and X drugs, and were 11.2, 7.3 and 8.2%, respectively, in the first, second and third trimesters. Salbutamol (albuterol), trimethoprim/sulfamethoxazole (co-trimoxazole), ibuprofen, naproxen and oral contraceptives were the most common C, D, X drugs used during pregnancy. CONCLUSION: About one in every five women uses FDA C, D and X drugs at least once during pregnancy, and the most common prescription drugs in pregnancy are antiasthmatic, antibiotics, nonsteroid anti-inflammation drugs, antianxiety or antidepressants and oral contraceptives.
LANGUAGE: eng
DATE OF PUBLICATION: 2008 May
DATE OF ELECTRONIC PUBLICATION: 20080221
DATE COMPLETED: 20080922
DATE REVISED: 20151119
MESH DATE: 2008/09/23 09:00
EDAT: 2008/02/22 09:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1038/jp.2008.6 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski